NovaBridge Biosciences

NBP · NASDAQ

$1.43+$0.125 (+9.62%)TodayMarket closed ·
Prev close $1.30

Who owns NBP

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 18.3% of NBP’s shares.

  • Everest Medicines Ltd6.0%
  • CBC Group5.0%
  • HHLR Advisors, Ltd.2.2%
  • Morgan Stanley & Co. LLC1.4%
  • Next 6 largest institutions3.7%
  • All other shareholders81.7%
Top institutional holders of NBP
HolderShares% of shares
Everest Medicines Ltd15.85M5.96%
CBC Group13.24M4.98%
HHLR Advisors, Ltd.5.98M2.25%
Morgan Stanley & Co. LLC3.65M1.37%
AIHC Capital Management Limited2.88M1.08%
Invus Public Equities Advisors, LLC2.00M0.75%
Candriam Luxembourg S.A.1.64M0.62%
Marshall Wace LLP1.23M0.46%
Candriam Belgium S.A.1.13M0.43%
Adage Capital Management, L.P.1.00M0.38%

Largest mutual fund holders

Top mutual fund holders of NBP
HolderShares% of shares
Candriam Equities L Oncology1.13M0.43%
E Fund Global Pharmaceutical Industry Mixed Seed Fund (QDII)1.03M0.39%
iShares Biotechnology ETF619.86K0.23%
Belfius Equities Cure508.38K0.19%
Charlemagne OAKS Emerging and Frontier Opportunities Fund315.60K0.12%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $577.30K (1 trade) and sold $154.27K (7 trades) of NBP on the open market.

Latest NBP insider transactions
InsiderTypeSharesValue
Dennis Phillip AndrewSale8.21K$5.83K
Dennis Phillip AndrewOption exercise10.30K—
Dennis Phillip AndrewOption exercise23.70K—
Cao Sean WuxiongSale107.98K$79.90K
Cao Sean WuxiongOption exercise45.32K—
Cao Sean WuxiongOption exercise102.23K—
Cao Sean WuxiongOption exercise104.24K—
Cao Sean WuxiongOption exercise235.14K—
Xu Cong ClaireSale3.28K$2.59K
Xu Cong ClaireOption exercise4.08K—

Short interest

Settled Sep 30, 2026

Shares short
3.28M
Days to cover
3.52
% of shares outstanding
1.23%
Average daily volume
931.89K
Change since last report
−12.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.